glp-1 for autoimmune The anti-inflammatory and immunological properties of Receptor Agonists Can GLP-1 Drugs Boost Immunity?

lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks

prescribing decisions are made by affiliated medical providers

If you have questions about what water to use, such as if it is not indicated on the label, call your doctor

No eggs, no cruciferous vegetables, no raw onions or garlic, no red meat, no whey protein